FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2333303595> ?p ?o ?g. }

• W2333303595 endingPage "1430" @default.
• W2333303595 startingPage "1424" @default.
• W2333303595 abstract "This study aimed to investigate whether single nucleotide polymorphisms (SNPs) in the promoter of the excision repair cross complementation group 5 (ERCC5) gene influences response to oxaliplatin-based chemotherapy. Eighty-three patients with cytologically or histologically confirmed advanced colorectal cancer (CRC), at least one measurable lesion and underwent oxaliplatin-based chemotherapy were studied. To this end, six polymorphisms (-1415C>T, -763A>G, -413C>T, +25A>G, +202C>T, +372C>T) in the ERCC5 promoter were selected for investigation. Genomic DNA was obtained from peripheral blood cells, and polymerase chain reaction-ligation detection reaction was used to analyze these SNPs. The chi(2) test or Fisher's exact test was then used to investigate the association between polymorphisms and chemotherapy response. Our results showed that the response rate among patients with the -763GG genotype (72.7%) was significantly higher than that of other genotypes (22.2% for AA genotype, p = 0.008 and 37.2% for AG genotype, p = 0.046 respectively). In addition, the response rate among patients with the +25AA genotype (75%) was significantly higher than that of other genotypes (24.1% for GG genotype, p = 0.004 and 35.7% for AG genotype, p = 0.022 respectively). Patients with the -763A/+25G haplotype had a higher risk of non-response to oxaliplatin chemotherapy compared to those carrying the -763G/+25A haplotype (OR 2.672, 95% CI 1.353-5.278, p = 0.004). However, no genetic variation was observed at site -413, and no significant association was found between the -1415C>T, +202C>T or +372C>T polymorphisms and chemotherapy response. Therefore, these data suggest that ERCC5 promoter polymorphisms at -763 and +25 may be important predictors of response to oxaliplatin chemotherapy." @default.
• W2333303595 created "2016-06-24" @default.
• W2333303595 creator A5000316108 @default.
• W2333303595 creator A5009906089 @default.
• W2333303595 creator A5010951409 @default.
• W2333303595 creator A5026321029 @default.
• W2333303595 creator A5027922054 @default.
• W2333303595 creator A5032656037 @default.
• W2333303595 creator A5033848098 @default.
• W2333303595 creator A5040705853 @default.
• W2333303595 creator A5046454314 @default.
• W2333303595 creator A5057694691 @default.
• W2333303595 creator A5063540755 @default.
• W2333303595 creator A5075662908 @default.
• W2333303595 creator A5083634448 @default.
• W2333303595 date "2009-07-15" @default.
• W2333303595 modified "2023-10-02" @default.
• W2333303595 title "ERCC5 promoter polymorphisms at –763 and +25 predict the response to oxaliplatin-based chemotherapy in patients with advanced colorectal cancer" @default.
• W2333303595 cites W1972248724 @default.
• W2333303595 cites W1976712578 @default.
• W2333303595 cites W1983426353 @default.
• W2333303595 cites W1984947226 @default.
• W2333303595 cites W1992082799 @default.
• W2333303595 cites W1993464731 @default.
• W2333303595 cites W1997909925 @default.
• W2333303595 cites W2000776312 @default.
• W2333303595 cites W2004718750 @default.
• W2333303595 cites W2036706547 @default.
• W2333303595 cites W2037030165 @default.
• W2333303595 cites W2040583830 @default.
• W2333303595 cites W2041509173 @default.
• W2333303595 cites W2044472248 @default.
• W2333303595 cites W2049812251 @default.
• W2333303595 cites W2052404098 @default.
• W2333303595 cites W2065223298 @default.
• W2333303595 cites W2065829703 @default.
• W2333303595 cites W2072345776 @default.
• W2333303595 cites W2083231946 @default.
• W2333303595 cites W2090794531 @default.
• W2333303595 cites W2092970313 @default.
• W2333303595 cites W2093847914 @default.
• W2333303595 cites W2096061159 @default.
• W2333303595 cites W2099154608 @default.
• W2333303595 cites W2112483303 @default.
• W2333303595 cites W2115837368 @default.
• W2333303595 cites W2121368761 @default.
• W2333303595 cites W2123728510 @default.
• W2333303595 cites W2130440774 @default.
• W2333303595 cites W2131602976 @default.
• W2333303595 cites W2133147430 @default.
• W2333303595 cites W2133709539 @default.
• W2333303595 cites W2137773292 @default.
• W2333303595 cites W2138360552 @default.
• W2333303595 cites W2139248078 @default.
• W2333303595 cites W2139687160 @default.
• W2333303595 cites W2146798192 @default.
• W2333303595 cites W2156613325 @default.
• W2333303595 cites W2159212221 @default.
• W2333303595 cites W2161563098 @default.
• W2333303595 cites W2166898290 @default.
• W2333303595 cites W2171762490 @default.
• W2333303595 cites W2285157229 @default.
• W2333303595 doi "https://doi.org/10.4161/cbt.8.14.8889" @default.
• W2333303595 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19458483" @default.
• W2333303595 hasPublicationYear "2009" @default.
• W2333303595 type Work @default.
• W2333303595 sameAs 2333303595 @default.
• W2333303595 citedByCount "34" @default.
• W2333303595 countsByYear W23333035952012 @default.
• W2333303595 countsByYear W23333035952013 @default.
• W2333303595 countsByYear W23333035952015 @default.
• W2333303595 countsByYear W23333035952016 @default.
• W2333303595 countsByYear W23333035952017 @default.
• W2333303595 countsByYear W23333035952019 @default.
• W2333303595 countsByYear W23333035952020 @default.
• W2333303595 countsByYear W23333035952022 @default.
• W2333303595 countsByYear W23333035952023 @default.
• W2333303595 crossrefType "journal-article" @default.
• W2333303595 hasAuthorship W2333303595A5000316108 @default.
• W2333303595 hasAuthorship W2333303595A5009906089 @default.
• W2333303595 hasAuthorship W2333303595A5010951409 @default.
• W2333303595 hasAuthorship W2333303595A5026321029 @default.
• W2333303595 hasAuthorship W2333303595A5027922054 @default.
• W2333303595 hasAuthorship W2333303595A5032656037 @default.
• W2333303595 hasAuthorship W2333303595A5033848098 @default.
• W2333303595 hasAuthorship W2333303595A5040705853 @default.
• W2333303595 hasAuthorship W2333303595A5046454314 @default.
• W2333303595 hasAuthorship W2333303595A5057694691 @default.
• W2333303595 hasAuthorship W2333303595A5063540755 @default.
• W2333303595 hasAuthorship W2333303595A5075662908 @default.
• W2333303595 hasAuthorship W2333303595A5083634448 @default.
• W2333303595 hasConcept C104317684 @default.
• W2333303595 hasConcept C121608353 @default.
• W2333303595 hasConcept C126322002 @default.
• W2333303595 hasConcept C135763542 @default.
• W2333303595 hasConcept C143998085 @default.
• W2333303595 hasConcept C153209595 @default.
• W2333303595 hasConcept C197754878 @default.

• next